Per Pfeiffer

14PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 12, 2026
Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resection.

Anders Christian Larsen, Susy Shim, Lene Bæksgaard

|Aug 14, 2025
Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One-Bag Protocols.

Trine Holm Rasmussen, Charlotte Gotthard Mortz, Per Pfeiffer

|Apr 29, 2025
Prevalence and management of immediate drug hypersensitivity observed during antineoplastic drug therapy.

Trine Holm Rasmussen, Charlotte Gotthard Mortz, Per Pfeiffer

|Oct 10, 2024
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.

Eric Van Cutsem, Joelle Collignon, Rikke L Eefsen

|Sep 26, 2024
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer.

Thierry André, Eric Van Cutsem, Julien Taieb

|Jan 11, 2024
Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies.

Line Schmidt Tarpgaard, Stine Brændegaard Winther, Per Pfeiffer

Pageof 3